Testing effectiveness (Phase 2)Study completedNCT00058006
What this trial is testing
Celecoxib in Treating Patients With Early-Stage Head and Neck Cancer or Non-Small Cell Lung Cancer
Who this might be right for
Head and Neck CancerLung Cancer
Northwestern University